Targeting Aging Pathways To Treat Chronic Disease

11:00 AM - 12:00 PM (PDT), Tuesday, June 14, 2022 ・ Session Room 1B

Aging is the primary risk factor for many chronic conditions, and diseases of aging represent an enormous unmet clinical need. Today’s convergence of basic research and technological progress enables the development of novel human therapeutics that treat chronic disease by targeting the fundamental mechanisms of aging. In this session, panelists will engage in a wide-ranging conversation encompassing the challenge and promise of identifying key longevity mechanisms as targets for novel drugs and bringing these drugs to market to treat disease in new ways. The session will be of broad interest to an audience interested in serving as investors, founders, drug developers, or researchers in the emerging field of longevity-based therapeutics.

Moderator
photo
CEO
BioAge Labs
Speakers
photo
Science Policy Analyst
photo
CEO
Rejuvenate Bio
photo
CHIEF EXECUTIVE OFFICER
Alkahest, Inc.
photo
Cofounder
Retro Biosciences
photo
Head of R&D
Life Biosciences
photo
CEO & Founder
Insilico Medicine US, Inc.